{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:59:20Z","timestamp":1782881960330,"version":"3.54.5"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Life Science Research Network Wales","award":["NRNPGSep1400"],"award-info":[{"award-number":["NRNPGSep1400"]}]},{"name":"Welsh Government\u2019s Ser Cymru"},{"name":"KU Leuven Research Fund","award":["C24\/18\/046"],"award-info":[{"award-number":["C24\/18\/046"]}]},{"name":"Research Foundation \u2013 Flanders","award":["FWO-SBO S007019N"],"award-info":[{"award-number":["FWO-SBO S007019N"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Following a drug repurposing approach, we aimed to investigate and compare the antibacterial and antibiofilm activities of different classes of phosphate prodrugs (HepDirect, cycloSal, SATE and mix SATE) of antiviral and anticancer FDA-approved nucleoside drugs [zidovudine (AZT), floxouridine (FUDR) and gemcitabine (GEM)] against a variety of pathogenic Gram-positive and -negative bacteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Ten prodrugs were synthesized and screened for antibacterial activity against seven Gram-negative and two Gram-positive isolates fully susceptible to traditional antibiotics, alongside six Gram-negative and five Gram-positive isolates with resistance mechanisms. Their ability to prevent and eradicate biofilms of different bacterial pathogens in relation to planktonic growth inhibition was also evaluated, together with their effect on proliferation, viability and apoptosis of different eukaryotic cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prodrugs showed decreased antibacterial activity compared with the parent nucleosides. cycloSal-GEM-monophosphate (MP) prodrugs 20a and 20b were the most active agents against Gram-positive bacteria (Enterococcus faecalis and Staphylococcus aureus) and retained their activity against antibiotic-resistant isolates. cycloSal-FUDR-MP 21a partially retained good activity against the Gram-positive bacteria E. faecalis, Enterococcus faecium and S. aureus. Most of the prodrugs tested displayed very potent preventive antibiofilm specific activity, but not curative. In terms of cytotoxicity, AZT prodrugs did not affect apoptosis or cell viability at the highest concentration tested, and only weak effects on apoptosis and\/or cell viability were observed for GEM and FUDR prodrugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among the different prodrug approaches, the cycloSal prodrugs appeared the most effective. In particular, cycloSal (17a) and mix SATE (26) AZT prodrugs combine the lowest cytotoxicity with high and broad antibacterial and antibiofilm activity against Gram-negative bacteria.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa268","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T19:09:55Z","timestamp":1594235395000},"page":"2864-2878","source":"Crossref","is-referenced-by-count":21,"title":["Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials"],"prefix":"10.1093","volume":"75","author":[{"given":"Fabrizio","family":"Pertusati","sequence":"first","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pileggi","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Richards","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Wootton","sequence":"additional","affiliation":[{"name":"Public Health Wales Microbiology Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-5768","authenticated-orcid":false,"given":"Thijs","family":"Van Leemputte","sequence":"additional","affiliation":[{"name":"Centre of Microbial and Plant Genetics, Kasteelpark Arenberg 20, bus 2460, B-3001 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leentje","family":"Persoons","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Herestraat 49-box 1043, Leuven 3000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"De Coster","sequence":"additional","affiliation":[{"name":"Centre of Microbial and Plant Genetics, Kasteelpark Arenberg 20, bus 2460, B-3001 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Centre of Microbial and Plant Genetics, Kasteelpark Arenberg 20, bus 2460, B-3001 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Daelemans","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Herestraat 49-box 1043, Leuven 3000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Steenackers","sequence":"additional","affiliation":[{"name":"Centre of Microbial and Plant Genetics, Kasteelpark Arenberg 20, bus 2460, B-3001 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McGuigan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Serpi","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"2020101416151501800_dkaa268-B1","author":"O\u2019Neill","year":"2014"},{"key":"2020101416151501800_dkaa268-B2","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1021\/acs.jmedchem.6b00325","article-title":"Nucleoside derived antibiotics to fight microbial drug resistance: new utilities for an established class of drugs?","volume":"59","author":"Serpi","year":"2016","journal-title":"J Med Chem"},{"key":"2020101416151501800_dkaa268-B3","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/jac\/dkx151","article-title":"Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors","volume":"72","author":"Yssel","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020101416151501800_dkaa268-B4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jac\/dkm240","article-title":"Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner","volume":"60","author":"Sandrini","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2020101416151501800_dkaa268-B5","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00081-07","article-title":"Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria","volume":"51","author":"Sandrini","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416151501800_dkaa268-B6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.dnarep.2010.11.007","article-title":"Toxicity and tolerance mechanisms for azidothymidine, a replication gap-promoting agent, in Escherichia coli","volume":"10","author":"Cooper","year":"2011","journal-title":"DNA Repair"},{"key":"2020101416151501800_dkaa268-B7","first-page":"19","article-title":"Induction of apoptosis by gemcitabine","volume":"22 Suppl 11","author":"Huang","year":"1995","journal-title":"Semin Oncol"},{"key":"2020101416151501800_dkaa268-B8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3389\/fmicb.2019.00952","article-title":"Nucleoside analogues as antibacterial agents","volume":"10","author":"Thomson","year":"2019","journal-title":"Front Microbiol"},{"key":"2020101416151501800_dkaa268-B9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2180-13-184","article-title":"Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs","volume":"13","author":"Sun","year":"2013","journal-title":"BMC Microbiol"},{"key":"2020101416151501800_dkaa268-B10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"2020101416151501800_dkaa268-B11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10096-011-1220-3","article-title":"Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains","volume":"30","author":"Jordheim","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020101416151501800_dkaa268-B12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2012.01.019","article-title":"Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin","volume":"39","author":"Jordheim","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2020101416151501800_dkaa268-B13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-006-0195-8","article-title":"Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells","volume":"58","author":"Jordheim","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"2020101416151501800_dkaa268-B14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1081\/NCN-120003288","article-title":"Synthesis and in vitro antibacterial activity of novel 5\u2032-O-analog derivatives of zidovudine as potential prodrugs","volume":"21","author":"Moroni","year":"2002","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2020101416151501800_dkaa268-B15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/128_2014_561","article-title":"Prodrugs of phosphonates and phosphates: crossing the membrane barrier","volume":"360","author":"Wiemer","year":"2015","journal-title":"Topics Curr Chem"},{"key":"2020101416151501800_dkaa268-B16","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","article-title":"Synthesis of nucleoside phosphate and phosphonate prodrugs","volume":"114","author":"Pradere","year":"2014","journal-title":"Chem Rev"},{"key":"2020101416151501800_dkaa268-B17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.antiviral.2006.04.011","article-title":"Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules","volume":"71","author":"Meier","year":"2006","journal-title":"Antiviral Res"},{"key":"2020101416151501800_dkaa268-B18","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/jm00020a007","article-title":"Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate","volume":"38","author":"Lefebvre","year":"1995","journal-title":"J Med Chem"},{"key":"2020101416151501800_dkaa268-B19","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/S0960-894X(98)00535-6","article-title":"Rational design of a new series of mixed anti-HIV pronucleotides","volume":"8","author":"Schlienger","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"2020101416151501800_dkaa268-B20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/jpet.104.075903","article-title":"Liver-targeted drug delivery using HepDirect prodrugs","volume":"312","author":"Erion","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"2020101416151501800_dkaa268-B21","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1073\/pnas.0511100103","article-title":"An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants","volume":"103","author":"Liberati","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020101416151501800_dkaa268-B22","first-page":"A.1","volume-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989","edition":"2nd edn. Cold"},{"key":"2020101416151501800_dkaa268-B23","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.83.14.5189","article-title":"Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent","volume":"83","author":"Fields","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020101416151501800_dkaa268-B24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1472-765X.2010.02885.x","article-title":"Staphylococcus aureus SH1000 and 8325-4: comparative genome sequences of key laboratory strains in staphylococcal research","volume":"51","author":"O\u2019Neill","year":"2010","journal-title":"Lett Appl Microbiol"},{"key":"2020101416151501800_dkaa268-B25","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/JB.184.19.5457-5467.2002","article-title":"SigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4","volume":"184","author":"Horsburgh","year":"2002","journal-title":"J Bacteriol"},{"key":"2020101416151501800_dkaa268-B26","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1128\/AAC.00035-16","article-title":"Modulation of the substitution pattern of 5-aryl-2-aminoimidazoles allows fine-tuning of their antibiofilm activity spectrum and toxicity","volume":"60","author":"Peeters","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416151501800_dkaa268-B27","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1128\/AEM.01262-08","article-title":"Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium","volume":"74","author":"Janssens","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"2020101416151501800_dkaa268-B28","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1016\/j.bmc.2011.04.026","article-title":"Structure-activity relationship of 2-hydroxy-2-aryl-2,3-dihydro-imidazo[1,2-a]pyrimidinium salts and 2N-substituted 4(5)-aryl-2-amino-1H-imidazoles as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa","volume":"19","author":"Steenackers","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"2020101416151501800_dkaa268-B29","first-page":"45","volume-title":"Studies in Natural Products Chemistry","author":"Matias","year":"2016"},{"key":"2020101416151501800_dkaa268-B30","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1128\/AAC.01415-16","article-title":"Mutational consequences of ciprofloxacin in Escherichia coli","volume":"60","author":"Song","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101416151501800_dkaa268-B31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.med.59.110106.132000","article-title":"Bacterial and fungal biofilm infections","volume":"59","author":"Lynch","year":"2008","journal-title":"Annu Rev Med"},{"key":"2020101416151501800_dkaa268-B32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1462-5822.2009.01323.x","article-title":"Evolving concepts in biofilm infections","volume":"11","author":"Hall-Stoodley","year":"2009","journal-title":"Cell Microbiol"},{"key":"2020101416151501800_dkaa268-B33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0885066609358952","article-title":"Prevention of central venous catheter bloodstream infections","volume":"25","author":"Walz","year":"2010","journal-title":"J Intensive Care Med"},{"key":"2020101416151501800_dkaa268-B34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1099\/0022-1317-50-7-582","article-title":"Staphylococcus epidermidis biofilms: importance and implications","volume":"50","author":"Gara","year":"2001","journal-title":"J Med Microbiol"},{"key":"2020101416151501800_dkaa268-B35","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/AEM.07454-11","article-title":"Transcriptional responses of Escherichia coli K-12 and O157:H7 associated with lettuce leaves","volume":"78","author":"Fink","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"2020101416151501800_dkaa268-B36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4161\/viru.2.6.18423","article-title":"Survival and control of Escherichia coli O157:H7 in foods, beverages, soil and water","volume":"2","author":"Chauret","year":"2011","journal-title":"Virulence"},{"key":"2020101416151501800_dkaa268-B37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.foodres.2011.01.038","article-title":"Salmonella biofilms: an overview on occurrence, structure, regulation and eradication","volume":"45","author":"Steenackers","year":"2012","journal-title":"Food Res Int"},{"key":"2020101416151501800_dkaa268-B38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nrmicro2907","article-title":"Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective","volume":"10","author":"Folkesson","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"2020101416151501800_dkaa268-B39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/joim.12004","article-title":"Biofilm infections, their resilience to therapy and innovative treatment strategies","volume":"272","author":"Romling","year":"2012","journal-title":"J Intern Med"},{"key":"2020101416151501800_dkaa268-B40","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1038\/sj.emboj.7600330","article-title":"Crystal structure of the bacterial nucleoside transporter Tsx","volume":"23","author":"Ye","year":"2004","journal-title":"EMBO J"},{"key":"2020101416151501800_dkaa268-B41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs?","volume":"12","author":"Allen","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"2020101416151501800_dkaa268-B42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41467-019-13660-x","article-title":"Inhibiting bacterial cooperation is an evolutionarily robust anti-biofilm strategy","volume":"11","author":"Dieltjens","year":"2020","journal-title":"Nat Commun"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/10\/2864\/33885311\/dkaa268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/10\/2864\/33885311\/dkaa268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T20:16:59Z","timestamp":1602706619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/10\/2864\/5874080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,7,20]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa268","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,20]]}}}